Epithelial Ovarian Cancer clinical trials

Explore recruiting epithelial ovarian cancer clinical trials.

Recruiting epithelial ovarian cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Epithelial Ovarian Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Induction of neo-antigen specific T cells by specialized cross-presenting dendritic cells in epithelial ovarian cancer patients treated with neoadjuvant chemotherapy, the NEODOC study

Netherlands

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Sentinel node detection with 99Tc albumin nanocolloid and indocianine green (ICG) in patients with epithelial ovarian cancer in early stages. Pilot study.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

PET imaging of tumors with strong desmoplastic reaction in pancreas, bile ducts, ventricle and ovaries by a novel tracer, 68Ga-FAPI-46 = Fibroblast Activation Protein Inhibitor

Sweden, Finland

Therapeutic exploratory (Phase II) EU CTIS Study details

MATAO MAintenance Therapy with Aromatase inhibitor in epithelial Ovarian cancer: a randomized double-blinded placebo-controlled multi-center phase III Trial (ENGOT-ov54/Swiss-GO-2/MATAO) including LOGOS (Low Grade Ovarian cancer Sub-study)

Germany, Austria

Therapeutic confirmatory (Phase III) EU CTIS Study details

The Effect of tinzaparin on Biomarkers in FIGO Stage III-IV Ovarian Cancer Patients Undergoing Neoadjuvant Chemotherapy – A randomized pilot study

Sweden

Therapeutic exploratory (Phase II) EU CTIS Study details

Letrozole for Estrogen/Progesterone Receptor positive low-grade serous Epithelial ovarian cancer. A randomized phase III trial. LEPRE Trial

Italy, Czechia

Therapeutic confirmatory (Phase III) EU CTIS Study details

Epithelial Ovarian Cancer trials by city

Epithelial Ovarian Cancer in Toronto Epithelial Ovarian Cancer in Vancouver Epithelial Ovarian Cancer in Montreal Epithelial Ovarian Cancer in Calgary Epithelial Ovarian Cancer in Edmonton Epithelial Ovarian Cancer in Ottawa Epithelial Ovarian Cancer in Winnipeg Epithelial Ovarian Cancer in Quebec City Epithelial Ovarian Cancer in Hamilton Epithelial Ovarian Cancer in Kitchener Epithelial Ovarian Cancer in London Epithelial Ovarian Cancer in Halifax Epithelial Ovarian Cancer in New York Epithelial Ovarian Cancer in Los Angeles Epithelial Ovarian Cancer in Chicago Epithelial Ovarian Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease